Form 8-K - Current report:
SEC Accession No. 0001104659-25-101382
Filing Date
2025-10-22
Accepted
2025-10-22 06:40:18
Documents
13
Period of Report
2025-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2529228d1_8k.htm   iXBRL 8-K 36297
2 EXHIBIT 99.1 tm2529228d1_ex99-1.htm EX-99.1 28533
  Complete submission text file 0001104659-25-101382.txt   239739

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20251021.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20251021_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20251021_pre.xml EX-101.PRE 22354
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2529228d1_8k_htm.xml XML 3570
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 10 EARLSFORT TERRACE DUBLIN 2 Ireland D02 T380 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 251408563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)